Organization
Inje University Busan Paik Hospital
3 abstracts
Abstract
A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02).Org: Inje University Busan Paik Hospital, Seoul St Mary’s Hospital, Pusan Yangsan National University Hospital, Soonchunhyang University Cheonan Hospital, Seoul Metropolitan Government Seoul National University Boramae Medical Center,
Abstract
A phase 1a/b study of BR101801, a PI3K γ/δ and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies.Org: Boryung Corporation, Samsung Medical Center, Seoul National University Cancer Research Institute, Seoul, Republic of Korea, Seoul National University Hospital, Asan Medical Center,
Abstract
Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea.Org: Chonnam National University Hwasun Hospital, Inje University Busan Paik Hospital, Korea University Guro Hospital, Hallym University Sacred Heart Hospital, Korea Cancer Center Hospital,